SHP2 and UGP2 are Biomarkers for Progression and Poor Prognosis of Gallbladder Cancer

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin 2008;58:71–96.
   PubMed Web of Science ®Google Scholar
• Jayaraman S., Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am 2010;39:331–342.
   PubMed Web of Science ®Google Scholar
• Reid KM, Ramos-De la Medina A, Donohue JH. Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg 2007;11:671–681.
   PubMed Web of Science ®Google Scholar
• Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol 2004;11:310–315.
   PubMed Web of Science ®Google Scholar
• Ootani T, Shirai Y, Tsukada K, Muto T. Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer 1992;69:2647–2652.
   PubMed Web of Science ®Google Scholar
• Roa JC, Tapia O, Cakir A, Basturk O, Dursun N, Akdemir D, et al. Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas. Mod Pathol 2011;24:1069–1078.
   PubMed Web of Science ®Google Scholar
• Park SB, Kim YH, Rho HL, Chae GB, Hong SK. Primary carcinosarcoma of the gallbladder. J Korean Surg Soc 2012;82:54–58.
   PubMed Web of Science ®Google Scholar
• Liu DC, Yang ZL. MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma. Diagn Cytopathol 2013;41:199–205.
   PubMed Web of Science ®Google Scholar
• Huang YS, Cheng CY, Chueh SH, Hueng DY, Huang YF, Chu CM, et al. Involvement of SHP2 in focal adhesion, migration and differentiation of neural stem cells. Brain Dev 2012;34:674–684.
   PubMed Web of Science ®Google Scholar
• Mohi MG, Neel BG. The role of Shp2 (PTPN11) in cancer. Curr Opin Genet Dev 2007;17:23–30.
   PubMed Web of Science ®Google Scholar
• Sulis ML, Parsons R. PTEN: from pathology to biology. Trends Cell Biol 2013;13:478–483.
   Web of Science ®Google Scholar
• Chan G, Kalaitzidis D, Neel BG. The tyrosine phosphatase Shp2 (PTPN11) in cancer. Cancer Metastasis Rev 2008;27:179–192.
   PubMed Web of Science ®Google Scholar
• Howlett M, Menheniott TR, Judd LM, Giraud AS. Cytokine signalling via gp130 in gastric cancer. Biochem Biophys Acta 2009;1793:1623–1633.
   PubMed Web of Science ®Google Scholar
• Neel BG, Gu H, Pao, L. The ‘Shp’ing news: SH2 domaincontaining tyrosine phosphatases in cell signaling. Trends Biochem Sci 2003;28:284–293.
   PubMed Web of Science ®Google Scholar
• Uhlen P, Burch PM, Zito CI, Estrada M, Ehrlich BE, Bennett AM. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling. Proc Natl Acad Sci USA 2005;103:2160–2165.
   Web of Science ®Google Scholar
• Muenst S, Obermann EC, Gao F, Oertli D, Viehl CT, Weber WP, et al. Src homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancer. Histopathology 2013;63:74–82.
   PubMed Web of Science ®Google Scholar
• Xie H, Huang S, Li W, Zhao H, Zhang T, Zhang D. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2)expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:234–242.
   PubMed Web of Science ®Google Scholar
• Jiang J, Jin MS, Kong F, Wang YP, Jia ZF, Cao DH, et al. Increased expression of tyrosine phosphatase SHP-2 in Helicobacter pylori-infected gastric cancer. World J Gastroenterol 2013:19:575–580.
   PubMed Web of Science ®Google Scholar
• Dong S, Li FQ, Zhang Q, Lv KZ, Yang HL, Gao Y, et al. Expression and clinical significance of SHP2 in gastric cancer. J Int Med Res 2012;40:2083–2089.
   PubMed Web of Science ®Google Scholar
• Tang C, Luo D, Yang H, Wang Q, Zhang R, Liu G, Expression of SHP2 and related markers in non-small cell lung cancer: a tissue microarray study of 80 cases. Appl Immunohistochem Mol Morphol 2013;21:386–394.
   PubMedGoogle Scholar
• Tassidis H, Brokken LJ, Jirström K, Bjartell A, Ulmert D, Härkönen A. Low expression of SHP-2 is associated with less favorable prostate cancer outcomes. Tumour Biol 2013;34:637–642.
   PubMed Web of Science ®Google Scholar
• Meng F, Zhao X, Zhang S. Expression and significance of SHP-2 in human papillomavirus infected cervical cancer. J Huazhong Univ Sci Technolog Med Sci 2012;32:247–251.
   PubMed Web of Science ®Google Scholar
• Cai P, Guo W, Yuan H, Li Q, Wang W, Sun Y, et al. Expression and clinical significance of tyrosine phosphatase SHP-2 in colon cancer. Biomed Pharmacother 2014;68:285–290.
   PubMed Web of Science ®Google Scholar
• Meng M, Geisler M, Johansson H, Harholt J, Scheller HV, Mellerowicz EJ, et al. UDP-glucose pyrophosphorylase is not rate limiting, but is essential in Arabidopsis. Plant Cell Physiol 2009;50:998–1011.
   PubMed Web of Science ®Google Scholar
• Nualart F, Los Angeles García M, Medina RA, Owen GI Glucose transporters in sex steroid hormone related cancer. Curr Vasc Pharmacol 2009;7:534–548.
   PubMed Web of Science ®Google Scholar
• Thorsen K, Schepeler T, Øster B, Rasmussen MH, Vang S, Wang K, et al. Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis. BMC Genomics 2011;12:505.
   PubMed Web of Science ®Google Scholar
• Pescador N, Villar D, Cifuentes D, Garcia-Rocha M, Ortiz-Barahona A, Vazquez S, et al. Hypoxia promotes glycogen accumulation through hypoxia inducible factor (HIF)-mediated induction of glycogen synthase 1. PLoS One 2010;5:e9644.
   PubMed Web of Science ®Google Scholar
• de Jonge HJ, Woolthuis CM, Vos AZ, Mulder A, van denBerg E, Kluin PM, et al. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML. Leukemia 2011;25:1825–1833.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Yang ZL, Zou Q, Cao LF, Tan XG, Jiang S, et al. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder. Pol J Pathol 2013;64:44–51.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu X, Bai M, Zhang L, Xue L, Yi J. Maternal deprivation enhances behavioral vulnerability to stress associated with miR-504 expression in nucleus accumbens of rats. PLoS One 2013;8:e69934.
   PubMed Web of Science ®Google Scholar
• Nishihara K, Nagai E, Izumi Y, Yamaguchi K, Tsuneyoshi M. Adenosquamous carcinoma of the gallbladder: a clinicopathological, immunohistochemical and flow-cytometric study of twenty cases. Jpn J Cancer Res 1994;85:389–399.
   PubMedGoogle Scholar
• Kondo M, Dono K, Sakon M, Shimizu J, Nagano H, Nakamori S, et al. Adenosquamous carcinoma of the gallbladder. Hepatogastroenterology 2002;49:1230–1234.
   PubMed Web of Science ®Google Scholar
• Li S, Wang L, Zhao Q, Liu Y, He L, Xu Q, et al. SHP2 positively regulates TGFβ1-induced epithelial-mesenchymal transition modulated by its novel interacting protein Hook1. J BiolChem 2014;289:34152–34160.
   PubMed Web of Science ®Google Scholar